April 2016, Vol 6, No 4

Darzalex (Daratumumab): First Anti-CD38 Monoclonal Antibody Approved for Patients with Relapsed Multiple Myeloma

By Lisa A. Raedler, PhD, RPh

Drug Updates, Hematologic Malignancies, Multiple Myeloma

Return on Investment with Nutritional Support for Patients with Cancer, Part 1

By Sheryl A. Riley, RN, OCN, CMCN

Medications Used for the Treatment of Colorectal Cancer and Associated ICD-10 Codes

Cancer Drug Coding, ICD Codes, Reimbursement

This detailed article of codes related to colorectal cancer is intended to assist practice managers and other healthcare providers and payers to ensure their proper use of coding and billing information associated with the treatment of patients with colorectal cancer Read More ›

Implementing a Robust HIPAA Compliance Program in a Medical Practice

Practice Management

Physicians Are Not Addressing Financial Distress in Patients with Cancer

Reirradiation of Pelvic Area Is Safe and Improves Quality of Life

By Phoebe Starr

Genitourinary Cancers

Real-World Data Show 2-Year Survival Predicts Long-Term Survival for Metastatic Germ-Cell Testicular Cancer

By Phoebe Starr

Genitourinary Cancers

Atezolizumab, a PD-L1 Inhibitor, Shows Impressive Results in Metastatic Urothelial Cancer

By Charles Bankhead

Genitourinary Cancers

Transplant Remains Best Upfront Treatment Option in Newly Diagnosed Myeloma

Hematologic Malignancies, Multiple Myeloma

Preparing for Compliance with USP 800: Unreimbursed Efforts of an Oncology Practice

By Robert D. Orzechowski, MBA, SPHR, SHRM-SCP

Page 1 of 2

1
2